GWAS |
- Apolipoprotein A1 levels ( 32203549)
- Apolipoprotein B levels ( 32203549)
- Bladder cancer ( 24163127 20972438)
- Blood metabolite levels ( 24816252)
- Blood metabolite ratios ( 24816252)
- Cholesterol, total ( 24097068 20686565)
- Coronary artery disease ( 29212778 33020668)
- Gut microbiota (bacterial taxa, hurdle binary method) ( 32572223)
- Insulin resistance/response ( 25798622)
- Iron status biomarkers (total iron binding capacity) ( 33536631)
- Iron status biomarkers (transferrin levels) ( 25352340)
- LDL cholesterol levels ( 32203549)
- LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Liver enzyme levels (alkaline phosphatase) ( 33972514)
- Liver enzyme levels (gamma-glutamyl transferase) ( 33972514)
- Liver injury in anti-tuberculosis drug treatment ( 31109976)
- Medication use (calcium channel blockers) ( 31015401)
- Medication use (HMG CoA reductase inhibitors) ( 31015401)
- Metabolic syndrome ( 31589552)
- Metabolic traits ( 21886157)
- Metabolite levels ( 23823483)
- Myocardial infarction ( 33532862)
- Night sleep phenotypes ( 27126917)
- Paclitaxel-induced neuropathy ( 23776197)
- Serum metabolite levels ( 33031748)
- Total cholesterol levels ( 28334899 33339817)
- Triglyceride levels ( 32203549 28334899 29403010 33339817 30698716)
- Triglyceride levels in current drinkers ( 30698716)
- Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Triglyceride levels x long total sleep time interaction (2df test) ( 31719535)
- Triglyceride levels x short total sleep time interaction (2df test) ( 31719535)
- Triglycerides ( 24097068 20686565)
- Urinary metabolite levels in chronic kidney disease ( 31959995)
- Urinary metabolite modules (eigenmetabolites) in chronic kidney disease ( 31959995)
- Urinary metabolites ( 26352407 21572414)
- Urinary metabolites (H-NMR features) ( 24586186)
- Youthful appearance (self-reported) ( 32339537)
|
- Alzheimer's disease ( 19734902 19734903 21627779 31473137)
- Alzheimer's disease (late onset) ( 21460841 30617256 24162737 28714976)
- Alzheimer's disease in APOE e4+ carriers ( 25778476)
- Alzheimer's disease in APOE e4- carriers ( 25778476)
- Alzheimer's disease or family history of Alzheimer's disease ( 33589840 30617256)
- Alzheimer's disease or fasting insulin levels (pleiotropy) ( 30805717)
- Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
- Autism spectrum disorder or schizophrenia ( 28540026)
- Family history of Alzheimer's disease ( 30617256)
- Lung adenocarcinoma ( 28604730)
- Lung cancer in ever smokers ( 28604730)
- Panic disorder ( 19165232)
- Refractive error ( 32231278)
- Schizophrenia ( 25056061 29483656)
- Smoking behaviour (cigarettes smoked per day) ( 31089300)
- Smoking initiation ( 33082346)
- Smoking status (ever vs never smokers) ( 30643258)
- Spherical equivalent or myopia (age of diagnosis) ( 29808027)
|